Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study

Overview of attention for article published in Digestive Diseases and Sciences, April 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 12 X users

Readers on

mendeley: 12 Mendeley

Summary X

So far, Altmetric has seen 12 X posts from 12 X users, with an upper bound of 9,867 followers.

RT @DrAnuraagJ: Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propen…

26 Jul 2023

Reply Repost Favourite

RT @DrAnuraagJ: Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propen…

26 Jul 2023

Reply Repost Favourite

Congratulations to Dr. @NarulaNeeraj on your public disclosure, “Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study” #ClinicalResearch @HamHealthSci https://t.co/Ya

30 Jun 2023

Reply Repost Favourite

RT @DrAnuraagJ: Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propen…

06 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.